Винницкий Национальный Медицинский Университет Им. Н.И. Пирогова
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Винницкий Национальный Медицинский Университет Им. Н.И. ПироговаfiledCriticalВинницкий Национальный Медицинский Университет Им. Н.И. Пирогова
Priority to UAU201403247UpriorityCriticalpatent/UA92638U/en
Publication of UA92638UpublicationCriticalpatent/UA92638U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for preventing the emergence of the primary end points in the patients with unstable angina with comorbid arterial hypertension consists in the use of Bisoprolol as beta-adrenoblocker at a daily dose of 5-10 mg, Perindopril as an inhibitor of angiotensin-converting enzyme at a daily dose of 5-10 mg, Atorvastatin as antisclerotic drug at a daily dose of 20 mg, and acetylsalicylic acid at a daily dose of 75 mg for two years.
UAU201403247U2014-03-312014-03-31Method for preventing emergence of primary end points in patients with unstable angina with comorbid arterial hypertension
UA92638U
(en)